Toggle light / dark theme

CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma

CAR T cells in primary CNS lymphoma.

Treatment options for primary central nervous system (CNS) lymphoma remain limited, particularly in relapsed or refractory disease. This case report explores the activity and CNS trafficking of tandem CD20/CD19 CAR T cells (zamtocabtagene autoleucel), addressing key questions about cellular therapy in CNS lymphoma and the potential role of dual-target CAR T strategies.


CD19-directed chimeric antigen receptor (CAR) T-cell (CAR T) therapy is a well-established treatment for B-cell malignancies, but accessibility, toxicities, lack of persistence, modest anti-tumor activity, restricted trafficking and tumor antigen escape are among its limitations.1 Concern for excessive neurotoxicity led to exclusion of patients with central nervous system (CNS) involvement from clinical trials, and primary CNS lymphoma (PCNSL) is an exclusion on the approved products’ labeling. PCNSL is a highly aggressive lymphoma, with a favorable response to initial chemotherapy/radiation, but compared with lymphomas outside the CNS, relapses are common, and survival is inferior. Moreover, there is a lack of approved standard care beyond first-line therapy and the prognosis for these PCNSL patients remains poor.2

In approximately one third of all B-cell lymphoma patients, resistance to CAR T and relapses are accompanied by CD19 downregulation. Preclinical evidence suggests that dual antigen-targeting may overcome this problem.3 To address antigen escape, the investigational anti-CD20/ anti-CD19 CAR T product MB-CART2019.1 (zamtocabtagene autoleucel [zamto-cel]) was designed. Zamto-cel is a dual-targeting tandem-CAR construct with scFv regions of anti-CD19 and anti-CD20 linked in sequence by a flexible interchain linker, followed by CD8, 4-1BB and CD3 ζ domains.4 Our group and others have evaluated zamto-cel in a pivotal phase II clinical trial (DALY II USA/ MB-CART2019.1; clinicaltrials gov. Identifier: NCT04792489) for the treatment of DLBCL patients who received at least two lines of treatment.5 In addition to addressing antigen escape/relapse zamto-cel is non-cryopreserved with a vein-to-vein time of 14 days, improving cell yield and potency.

CERN’s Medipix3 technology on track to help more patients

Originally derived from a technology developed to explore the fundamental nature of the Universe, Medipix3 technology now powers a medical scanner that is on track to benefit an increased number of patients. MARS Bioimaging Ltd has received 510(k) clearance from the US Food and Drug Administration (FDA) for its portable photon-counting CT scanner for upper-limb imaging, allowing the system to enter the US health sector and enable broader clinical adoption.

Medipix technology is based on hybrid pixel detectors, which were originally designed at CERN for particle detection in high-energy physics experiments. This technology was adapted to create the Medipix family of pixel detector readout chips, enabling a new approach to medical imaging.

Unlike conventional CT (computed tomography) systems – which combine X-ray measurements taken from different angles to produce a 3D image – photon-counting technology measures individual X-ray photons and their energy. This produces detailed, three-dimensional images that help clinicians to distinguish between different types of tissue and materials, better informing their decision making. As Dr John Carrino, a prominent musculoskeletal radiologist involved in clinical trials with MARS Bioimaging, notes: “Photon-counting CT is going to be the future of CT for medical imaging.”

Hydraulic brain: Body motion linked to fluid movement in the brain

The brain is more mechanically connected to the body than previously appreciated, scientists report in Nature Neuroscience. Through a study using mice and simulations, the team found a potential biological mechanism underlying why exercise is thought to benefit brain health: abdominal contractions compress blood vessels connected to the spinal cord and the brain, enabling the organ to gently move within the skull. This swaying facilitates the surrounding cerebrospinal fluid to flow over the brain, potentially washing away neural waste that could cause problems for brain function.

According to Patrick Drew, professor of engineering science and mechanics, of neurosurgery, of biology and of biomedical engineering at Penn State, the work builds on previous studies detailing how sleep and neuron loss can influence how and when cerebrospinal fluid flushes through the brain.

“Our research explains how just moving around might serve as an important physiological mechanism promoting brain health,” said Drew, corresponding author on the paper. “In this study, we found that when the abdominal muscles contract, they push blood from the abdomen into the spinal cord, just like in a hydraulic system, applying pressure to the brain and making it move.

Frontiers: Introduction:

Alzheimer’s disease, a progressive neurodegenerative disorder, is marked by beta-amyloid plaque accumulation and cognitive decline. The limited efficacy and significant side effects of anti-amyloid monoclonal antibody therapies have prompted exploration into innovative treatments like focused ultrasound therapy. Focused ultrasound shows promise as a non-invasive technique for disrupting the blood–brain barrier, potentially enhancing drug delivery directly to the brain and improving the penetration of existing therapeutic agents.

The fake disease that fooled the internet, and what it says about all of us

Until a few years ago, no one had heard of bixonimania. Then, in 2024, a group of scientists posted findings online announcing the condition, which they claimed affected the eyes after computer use. However, the scientists had made it up—not just the work, but the authors’ names, affiliations, locations and funding, which was the University of Fellowship of the Ring and the Galactic Triad.

Large language models like ChatGPT and Gemini treated it as real anyway, and in doing so, helped turn a fictional disease into a legitimate-sounding health concern.

Bixonimania is not an isolated case. Being deceived—whether you are a person or an AI model—is concerningly common, in science and beyond. Whether we’re talking about AI hallucinations, state-backed disinformation or just everyday lies, humans have a remarkable knack for naivety, owing to our biases and increasing need to outsource learning to others. These are problems we—individually and collectively—urgently need to better understand and overcome.

New deadly disease outbreak map flags ‘highly vulnerable’ regions around the world

New global modeling shows that about 9.3% of the world’s land area is highly vulnerable to the risk of dangerous disease outbreaks.

These hotspots are concentrated in Latin America and Oceania, where communities already face pressure from climate change and land development.

The research also identifies the countries most vulnerable to outbreaks – and the least equipped to detect and contain them.

Phosphoinositide Depletion and Compensatory Phospho-Signaling in Angiotensin II-Induced Heart Disease

Westhoff & colleagues found that PTEN inhibition reduces cardiac fibrosis caused by the high blood pressure hormone AngII. Learn how to fight fibrosis from hypertension at.


This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.

Chip Can Project Video the Size of a Grain of Sand

Engineers have created a 1-square-millimeter chip that can project a photograph onto an area smaller than the size of two human egg cells. This precise laser control could have applications in augmented reality, biomedical imaging, and quantum computing.


MEMS array to steer lasers for quantum computer finds other uses.

New Insight into Bone Immunity in Marrow Cavity and Cancellous Bone Microenvironments and Their Regulation

Bone immunity represents a dynamic interface where skeletal homeostasis intersects with systemic immune regulation. We synthesize emerging paradigms by contrasting two functionally distinct microenvironments: the marrow cavity, a hematopoietic and immune cell reservoir, and cancellous bone, a metabolically active hub orchestrating osteoimmune interactions. The marrow cavity not only generates innate and adaptive immune cells but also preserves long-term immune memory through stromal-derived chemokines and survival factors, while cancellous bone regulates bone remodeling via macrophage-osteoclast crosstalk and cytokine gradients. Breakthroughs in lymphatic vasculature identification challenge traditional views, revealing cortical and lymphatic networks in cancellous bone that mediate immune surveillance and pathological processes such as cancer metastasis.

🧠 The Emotional Brain Under Stress: How the Amygdala Connects Chronic Stress to Chronic Disease

We often think of stress as something that just “gets on our nerves,” but what if it’s actually reshaping our brain — and our long-term health?A recent scientific review published in Biomedicine & Pharmacotherapy by Juhyun Song (2023) highlights a fascinating and urgent connection between the brain’s emotional hub — the amygdala — and our rising burden of metabolic diseases, dementia, and mental health disorders. This tiny almond-shaped structure deep in our brain does more than generate fear or

/* */